A297 disorders: 0.1263, 0.2265, 0.02604, 0.0136; (Log) Number of previous fractures: 0.02572, 0.004297, 0.04713, 0.0186; (Log) Age: 0.07413, 0.008808, 0.1394, 0.0261; Ongoing congestive: 0.06264, 0.006147, 0.1191, 0.0298 for Parameter Estimate, Lower 95% CI, Upper 95% CI, P value, respectively. *Cohort p 0.0001 Defined by OPAG. Investigator site included as a random effect.
PIH38 RELATIONSHIP BETWEEN HEALTH-RELATED QUALITY OF LIFE AND MULTIMORBIDITY AMONG OLDER PERSONS IN GERMANY-RESULTS OF THE PRISCUS-COHORT
Hodek JM, Greiner W University of Bielefeld, Bielefeld, Germany OBJECTIVES: Changed morbidity patterns in many industrialised countries lead to new requirements concerning the health care process. In contrast to a complete cure and due to increasing multiple chronic conditions with longevity, the alleviation of complaints and thereby securing the health-related quality of life (HRQoL) is more and more in the focus of efforts. Aim of this study is to analyse the effects of multiple chronic conditions on HRQoL in elderly people ( 70 years). METHODS: Based on data from the getABI cohort (PRISCUS), empirical analyses were conducted. To evaluate HRQoL a representative sample of 2,120 older participants (76.29 4.48 years, 46.3% male) from Germany provided information on their current health status and completed the EQ-5D and the SF-8-questionnaires. RESULTS: Findings show clearly, that the existence of multiple chronic conditions (and not the ageing alone) has negative effects on HRQoL (p 0.000). There is an inverse relationship between HRQoL and multimorbidity in the elderly. In comparison to mental dimensions (p 0.234), physical domains are affected significantly stronger by an increasing number of diseases (p 0.000). Particularly new cardiovascular and cerebrovascular diseases in the last two years, the long-term existence of peripheral arterial disease and dysfunctions of the musculoskeletal system result in severe losses of HRQoL. On the contrary, other chronic conditions (hypertension, diabetes, lipometabolic disorder) or events more than two years ago do not have significant influence on HRQoL. CONCLUSIONS: A clear understanding of the impacts of specific morbidity patterns on HRQoL in elderly persons can help to ensure an extensive and comprehensive health care process and to optimise it in the patients´ sense. This optimised process should not separate between single diagnoses, but focus on the concurrence of multiple conditions.
PIH39 VALIDITY AND RELIABILITY OF QUALITY OF LIFE ENJOYMENT AND SATISFACTION QUESTIONNAIRE FOR TURKISH WOMEN
Malhan S 1 , Oksuz E 1 , Baytar S 2 , Tulunay FC 3 1 Baskent University, Ankara, Turkey, 2 Baskent University, ankara, Turkey, 3 Ankara University Medical School, Ankara, Turkey OBJECTIVES: The aim of this study was to determine the reliability and validity of the Quality of Life Enjoyment and Satisfaction Questionnaire (QLESQ) for Turkish women. METHODS: The data were collected through sociodemografic questionnaire, QLESQ and EuroQol. The scale, which was translated into English from Turkish, again translated back into English by two independent translators, was applied to 168 female subjects. The females above 25 consisted of 85 housewives and 83 working women. The scale was applied to 74 females in the pretest phase. The EuroQol-5D was used for concurrent validity. The EuroQol-5D was used for concurrent validity. Cronbach's Alfa was used to assess reliability, and factor analysis to assess dimensionality. RESULTS: The internal consistency coefficient (Cronbach's alpha) of QLESQ was 0.93. Factor analysis of the scale revealed that it was composed of three factors with Eigenvalues 2, accounting for 62.0% of the total variance. All items of the Turkish QLESQ had a factor load ranging from 0.22 to 0.76 There was a strong relationship between QLESQ, and EuroQoL 5D. CONCLUSIONS: The QLESQ has good validity and reliability for Turkish women.
PIH40 WILLINGNESS TO PAY PER QUALITY-ADJUSTED LIFE YEAR OF CHRONIC PROSTATITIS PATIENTS IN CHINA
Zhao FL 1 , Wu JH 2 , Yue M 2 , Li SC 1 1 University of Newcastle, Callaghan, Australia, 2 306 Hospital of PLA, Beijing, China OBJECTIVES: Willingness to pay (WTP) per quality-adjusted life year (QALY) has been suggested as the threshold of cost-effectiveness analysis (CEA) in evaluating health technology. This study is to estimate the WTP/QALY in Chinese patients with chronic prostatitis (CP). METHODS: A consecutive sample of CP outpatients who visited 306 Hospital of PLA in Beijing, China at the beginning of 2009 was recruited. Their health related utility was assessed through EQ-5D and SF-6D; and their health status with EQ-VAS and National Institutes of Health-Chronic Prostatitis Symptom Index. A closed-ended iterative bidding contingent valuation method was used to elicit WTP for a hypothetical perfect health. WTP/QALY was calculated with the utility and WTP value elicited in this study. Multiple linear regression model was run to identify the effect of factors on the magnitude of WTP/QALY. RESULTS: After informed consent, 178 CP patients participated in the study. Mean (SD) EQ-5D and SF-6D utility weights were comparable at 0.74 (0.13) and 0.75 (0.09) respectively. WTP/QALY were estimated at US$8197 with EQ-5D and US$7684 with SF-6D, which were much lower than the often-cited threshold of cost-effectiveness analysis. Compared with the threshold recommended by World Health Organization, which is 1-3 times of gross domestic product per capita, WTP/QALY from this study were also at the lower bound. Working and unmarried Patients with higher household income were willing to pay more for a QALY. CONCLUSIONS: As the first study to estimate the WTP/QALY in China, this study demonstrated that question for WTP in this study is acceptable and feasible in Chinese CP patients, and the method to calculate WTP/ QALY produced meaningful answers. The lower WTP/QALY compared with the often-cited threshold of CEA suggests that WTP/QALY elicited from patients may not provide insight into societal valuations of medical expenditures.
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PIH41 PRESCRIPTION PATTERNS AND EXPENDITURE OF LONG-TERM BENZODIAZEPINE TREATMENT IN ELDERLY OUTPATIENTS IN TAIWAN
Cheng JS 1 , Chen CY 2 , Lin KM 3 , Shih YT 2 1 National Health Research Institutes, Jhunan Town, Miaoli County, Taiwan, 2 National Health Research Institutes, Zhunan Town, Miaoli County, Taiwan, 3 National Health Research Institutes, Taipei, Taiwan OBJECTIVES: Benzodiazepine (BZD) treatment of prolonged periods and higher dosage is not recommended for the elderly. Because of free choice of physicians and the absence of gatekeepers in Taiwan, this study aimed to identify prescription patterns and expenditure for long-term BZD treatment in elderly outpatients, and examine factors associated with the prescription overlap. METHODS: This study used a sampling database from the Bureau of National Health Insurance. Subjects were included if they were aged 65 or over and had received any BZD prescription in 2002. Received BZDs were divided into prescribed and overlapped quantities in terms of defined daily doses (DDDs) and expenditure. Single long-term prescriber was defined as receiving more than 180 supply days from one department. The logistic model and multivariate regression models were used to evaluate associations of factors with the prescription overlap and quantities of overlap, respectively. RESULTS: In 2002, 1705 out of 7561 elderly individuals had received BZDs with more than 180 prescription-covered days. Prescription overlap represented 10% of both their DDDs and expenditure. There were 107 subjects who had no single long-term prescriber and 362 subjects with more than 30 prescription-overlap days. Men, mental illness(es), comorbidities, multiple prescribers with or without a single long-term prescriber, and higher prescribed dose were associated with an increased likelihood of prescription overlap. Increased age, depression, a single long-term prescriber with or without multiple prescribers, and increased prescribed dose were correlated with increased overlapped DDD and expenditure. CONCLUSIONS: Eighteen percent of the elderly with long-term BZD treatment were not under the authority of a single prescriber, and the prescription overlap was highly concentrated in 21% of them. Multiple prescribers increased the probability of prescription overlap. Individuals with a single long-term prescriber and multiple prescribers had a higher risk of prescription overlap, and higher overlapped BZD DDDs and expenditure.
